Arlette Faye Kreager

Title: Arlette Faye Kreager: Innovator in Pharmaceutical Processes

Introduction

Arlette Faye Kreager is a notable inventor based in Avon, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the dissolution rates of medications. His innovative work has led to the granting of a patent that addresses critical aspects of pharmaceutical formulation.

Latest Patents

Kreager holds a patent for a process aimed at preparing pharmaceutical bulk material with uniform dissolution. The patent, titled "Process for preparing pharmaceutical bulk material having uniform dissolution," describes a method for producing cefaclor crystalline bulk material. This process ensures that the dissolution rate in a capsule reaches ≥80% in water within 30 minutes. One of the key steps involves reducing the water content of cefaclor dihydrates to create a form with ≤2% water content. This lower water content cefaclor can then be rehydrated to a specific range without negatively impacting the dissolution rate.

Career Highlights

Kreager is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and quality in drug development. His work at Eli Lilly has allowed him to focus on improving pharmaceutical formulations, which is crucial for patient outcomes.

Collaborations

Throughout his career, Kreager has collaborated with esteemed colleagues, including Frank Brown, Jr. and Robert Alan Forbes. These partnerships have fostered an environment of innovation and have contributed to the advancement of pharmaceutical processes.

Conclusion

Arlette Faye Kreager's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to enhancing medication efficacy. His work continues to impact the field positively, ensuring better health outcomes for patients.